Gabe Mintier
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Drug Transport and Resistance Mechanisms
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
-
- Drug-Induced Hepatotoxicity and Protection 1
- Pharmacogenetics and Drug Metabolism 1
-
- Pharmacological Effects and Toxicity Studies 3
- Co-authors
- John N. Feder (5 shared papers)Qi Guo (2 shared papers)Hong Shen (3 shared papers)A. David Rodrigues (3 shared papers)Punit Marathe (2 shared papers)Xia Xiao (1 shared paper)Dehua Zhao (1 shared paper)Charles Tilford (1 shared paper)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Scientific Reports (1 paper)Protein Expression and Purification (1 paper)Analytical Biochemistry (1 paper)Drug Metabolism and Disposition (1 paper)
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Gabe Mintier
8 papers receiving 288 citations
Peers
Comparison fields: 5 of 62
- Pharmacology 61
- Oncology 151
- Pediatrics, Perinatology and Child Health 68
- Business and International Management 6
- Clinical Biochemistry 14
Countries citing papers authored by Gabe Mintier
This map shows the geographic impact of Gabe Mintier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabe Mintier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabe Mintier more than expected).
Fields of papers citing papers by Gabe Mintier
This network shows the impact of papers produced by Gabe Mintier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabe Mintier. The network helps show where Gabe Mintier may publish in the future.
Co-authors
The 25 scholars most cited alongside Gabe Mintier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 68 | |
| 2 | 2018 | 44 | |
| 3 | 2006 | 36 | |
| 4 | 2017 | 32 | |
| 5 | 2015 | 29 | |
| 6 | 2015 | 29 | |
| 7 | 2016 | 27 | |
| 8 | 2005 | 24 |
About Gabe Mintier
Gabe Mintier is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Clinical Biochemistry, Oncology and Immunology, having authored 8 papers that have together received 289 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers), CRISPR and Genetic Engineering (2 papers), Metabolism and Genetic Disorders (1 paper), Drug-Induced Hepatotoxicity and Protection (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Immunotherapy and Immune Responses (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Pharmacology (61 citations), Oncology (151 citations), Pediatrics, Perinatology and Child Health (68 citations), Business and International Management (6 citations) and Clinical Biochemistry (14 citations). Gabe Mintier has collaborated with scholars based in United States, Germany and India. Frequent co-authors include John N. Feder, Qi Guo, Hong Shen, A. David Rodrigues, Punit Marathe, Xia Xiao, Dehua Zhao, Charles Tilford, Mohammed Jemal and Isaac Neuhaus. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Scientific Reports, Protein Expression and Purification, Analytical Biochemistry and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.